MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
13.56
+0.49
+3.75%
Opening 13:05 04/08 EDT
OPEN
13.85
PREV CLOSE
13.07
HIGH
13.98
LOW
13.33
VOLUME
153.69K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
11.60
MARKET CAP
192.63M
P/E (TTM)
-0.9306
1D
5D
1M
3M
1Y
5Y
1D
Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash
Reuters · 1d ago
Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Nuvalent (NUVL) and Tonix Pharma (TNXP)
TipRanks · 2d ago
Weekly Report: what happened at TNXP last week (0330-0403)?
Weekly Report · 2d ago
Insiders Shake Up Vale, Gevo, Macy’s, Tonix, Southern
TipRanks · 4d ago
Tonix Pharma CEO Makes Bold Insider Move Amid Market Uncertainty
TipRanks · 6d ago
Tonix CEO Seth Lederman buys TNXP shares worth $0.1 million
Reuters · 04/01 13:31
Tonix publishes investor presentation highlighting TONMYA fibromyalgia launch and early sales traction
Reuters · 04/01 13:29
Tonix publishes presentation on long-acting monoclonal antibody to prevent Lyme disease
Reuters · 03/31 22:25
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.